Drag a card by its title · ⚙ to size, swap or remove

The company

Sonoma Pharmaceuticals, Inc.

SNOA · Nasdaq

Health CareMedical DevicesNot moving yet

SNOA stood above a rising 150-day average in 3 of the last 52 weekly readings, and has been out of that trend for the last 49 weeks. It is 20.5% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 49
Industry in uptrend: 27% -9 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $0
Officials’ trades on record: 0
Institutions holding: 14 (-2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 3 of 52 weeks.

17 Apr – 16 Oct

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months0

Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders14-2 on the quarter

New · exited4 · 6

Reported value$136K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
RENAISSANCE TECHNOLOGIES LLCnew · filed 13 Aug 2026	40,468$50K	+40,468
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	26,787$33K	+6,846+34.3%
VANGUARD CAPITAL MANAGEMENT LLCunchanged · filed 13 Aug 2026	18,787$23K	00.0%
McKinley Carter Wealth Services, Inc.unchanged · filed 28 Jul 2026	11,193$14K	00.0%
UBS Group AGadded · filed 13 Aug 2026	7,808$9,604	+7,802+130033.3%
Global Retirement Partners, LLCnew · filed 6 Aug 2026	2,548$3,134	+2,548
MORGAN STANLEYreduced · filed 13 Aug 2026	2,000$2,460	-4−0.2%
OSAIC HOLDINGS, INC.unchanged · filed 14 Aug 2026	500$615	00.0%
BARCLAYS PLCnew · filed 14 Aug 2026	459$565	+459
BlackRock, Inc.unchanged · filed 7 Aug 2026	113$139	00.0%

30 Jun 2024 – 30 Jun 2026

News

No headline names it lately.

Everyone who traded it

Amy Moss Trombly Chief Executive Officer · last 9 Jul 20260 · 0

Jerome J. Dvonch Chief Financial Officer · last 9 Jul 20260 · 0

John McLaughlin Director · last 9 Jul 20260 · 0

Philippe Weigerstorfer Director · last 9 Jul 20260 · 0

Poggetto John Dal Controller · last 9 Jul 20260 · 0

Vanessa Jacoby Director · last 9 Jul 20260 · 0

Jay E. Birnbaum Director · last 2 Jan 20260 · 0

Bruce Thornton Executive VP and COO · last 19 Jun 20250 · 0

Chad Norman White Chief Financial Officer · last 29 Dec 20220 · 0

Robert Grant Edwards Chief Financial Officer · last 23 Apr 20200 · 0

James J. Schutz Other · last 14 Jan 201916 · 0

Robert E. Miller Other · last 14 Jan 201912 · 0

Same industry

RCEL Avita MedicalLeading+100%

ATRC AtriCureLeading+49%

HAE HaemoneticsLeading+48%

HTFL HeartflowLeading+40%

PLSE Pulse BiosciencesLeading+33%

INFU InfuSystems HoldingsLeading+27%

SMTI Sanara MedTechLeading+26%

ITGR Integer HoldingsLeading+23%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2026 · to 31 Mar 202638.0%

Operating profit marginFY 2026 · to 31 Mar 2026-12.6%

Free cash flow marginFY 2026 · to 31 Mar 2026-21.1%

Return on capital employedFY 2026 · to 31 Mar 2026-27.0%

Debt to equityFY 2026 · to 31 Mar 20260.07×

Research spendFY 2026 · to 31 Mar 202611.6%

Share count trendFY 2026 · to 15 Jun 2026166%

Cash and equivalentsFY 2026 · to 31 Mar 2026$2.4M

Free cash flowFY 2026 · to 31 Mar 2026−$4.1M

Analyst forecasts

No analyst forecasts yet.